Investment Calls: Regeneron, Booking Holdings, General Dynamics, and Fiserv Stock Analysis

Regeneron: Top Pick for 2026

• 💡 Regeneron is highlighted as a top pick for 2026, trading at 16.5 times earnings with a 5% free cash flow yield and 20% earnings growth.
• 🚀 Despite shares being down 1% this year, the company boasts one of the largest drug pipelines in pharma and biotech, with its main drug, Dupixent, growing well.
• 🎯 The stock is considered reasonably cheap with strong earnings growth prospects, making it a potential momentum play for the next year.

Booking Holdings: Travel Industry Strength

• ✈️ Booking Holdings is a top pick from BTIG with a new price target of $6,250, signaling expectations for a strong fundamental year.
• 📈 The stock has already seen a 14% increase, recovering from a sharp decline, attributed to continued strong consumer spending supporting the travel industry.

General Dynamics: Defense Sector Leader

• 🛡️ General Dynamics is identified as a top defense pick with a target of $400, benefiting from strong US defense spending.
• naval assets, particularly in the South China Sea, where a significant portion of global trade occurs.
• 📊 The stock is technically well-positioned, trading above critical moving averages, making it an attractive entry point.

Fiserv: A Deep Dive into Challenges and Potential

• 📉 Fiserv is experiencing its worst year, down 68% year-to-date, yet Mizuho maintains an outperform rating with a $110 target, suggesting a potential doubling from its current price.
• 💰 The company's management is reportedly laser-focused on returning to growth, with potential for double-digit earnings growth, an 8x earnings multiple, and an 11% free cash flow yield.
• ⚠️ The significant stock decline is attributed to issues with sales to Argentina and a subsequent credibility problem, despite having a strong product like Clover used by small businesses.
• 🔄 A new management team has been in place for about a year, working to clear the decks and rebuild credibility, though it may take one or two more quarters to assess their effectiveness.
• ⚖️ The stock presents a complex situation for shareholders, with some holding gains and others significant losses, leading to strategic considerations around tax loss harvesting.